V. Alfieri (Parma (PR), Italy), G. Margaritopoulos (London, United Kingdom)
Immune alveolitis profile in bronchoalveolar lavage of infiltrative lung diseases: not just counting matters.
A. Moui (Nantes, France), S. Dirou (Nantes, France), C. Sagan (Nantes, France), R. Liberge (Nantes, France), C. Defrance (Nantes, France), P. Arrigoni (Nantes, France), O. Morla (Nantes, France), C. Kandel-Aznar (Nantes, France), A. Tissot (Nantes, France), E. Eschapasse (Nantes, France), T. Goronflot (Nantes, France), A. Magnan (Nantes, France), F. Blanc (Nantes, France)
|   |
Connective tissue disease-associated interstitial lung diseases and interstitial pneumonia with autoimmune features: different entities?
M. Sanchez Mitacc (Barcelona, Spain), H. Torres-Zevallos (Lima, Peru), N. Albacar (BARCELONA, Spain), J. Francesqui (BARCELONA, Spain), S. Cuerpo (BARCELONA, Spain), C. Lucena (BARCELONA, Spain), M. Boada (BARCELONA, Spain), G. Espinosa (BARCELONA, Spain), R. Castellanos (BARCELONA, Spain), O. Viñas (BARCELONA, Spain), E. Ruiz (BARCELONA, Spain), A. Pérez (BARCELONA, Spain), C. Agustí (BARCELONA, Spain), S. Prieto (BARCELONA, Spain), J. Ramírez (BARCELONA, Spain), M. Sánchez (BARCELONA, Spain), F. Hernández-Gonzáles (BARCELONA, Spain), J. Sellares (BARCELONA, Spain)
| |
Idiopathic pulmonary fibrosis and gastroesophageal reflux disease: A population-based case-control study
M. Baqir (Rochester, United States of America), A. Vu (Rochester, United States of America), T. Moua (Rochester, United States of America), A. Vasireddy (Pittsfield, United States of America), A. Chamberlain (Rochester, United States of America), R. Frank (Rochester, United States of America), J. Ryu (Rochester, United States of America)
| |
The relationship between GAP stage and quality of life in IPF and systemic sclerosis-related ILD is diagnosis-dependent
M. Durheim (Oslo, Norway), A. Hoffman-Vold (Oslo, Norway), T. Eagan (Bergen, Norway), A. Hovden (Asker, Norway), M. Lund (Oslo, Norway), G. Bjerke (Lørenskog, Norway), T. Jonassen (Bergen, Norway), O. Johansen (Asker, Norway), T. Sjåheim (Oslo, Norway)
| |
Factors associated with right ventricular dysfunction among patients with chronic hypersensitivity pneumonitis
E. Leonova (Moscow, Russian Federation), E. Shmelev (Moscow, Russian Federation), E. Shergina (Moscow, Russian Federation)
| |
Evaluation of cardiac function by echocardiography in patients with interstitial lung disease, divided by ILD group
V. Martínez Vázquez (Ciudad de Mexico, Mexico), A. Orea Tejeda (Ciudad de Mexico, Mexico), D. González Islas (Ciudad de Mexico, Mexico), M. Quintero Martínez (Ciudad de Mexico, Mexico), R. Sánchez Santillan (Ciudad de Mexico, Mexico), Y. Gastelum Ayala (Ciudad de Mexico, Mexico), O. Martínez Reyna (Ciudad de Mexico, Mexico), I. Pérez García (Ciudad de Mexico, Mexico), N. Martínez Luna (Ciudad de Mexico, Mexico), M. Gómez Martínez (Ciudad de Mexico, Mexico), L. Verdeja Vendrell (Ciudad de Mexico, Mexico), I. Buendía Roldan (Ciudad de Mexico, Mexico), M. Mejía Ávila (Ciudad de Mexico, Mexico), R. Robles Hernández (Ciudad de Mexico, Mexico), A. Velázquez Montes (Ciudad de Mexico, Mexico)
| |
Prognostic significance of pathologically proven chronic fibrosing interstitial lung diseases with a progressive phenotype (PF-ILDs): single center retrospective cohort
Y. Nakamura (nagasone city, Japan), T. Takimoto (nagasone city, Japan), T. Arai (nagasone city, Japan), N. Takeuchi (nagasone city, Japan), R. Sugawara (nagasone city, Japan), K. Katayama (nagasone city, Japan), S. Minomo (nagasone city, Japan), C. Sugimoto (nagasone city, Japan), K. Tachibana (nagasone city, Japan), M. Akira (nagasone city, Japan), T. Kasai (nagasone city, Japan), S. Hayashi (nagasone city, Japan), Y. Inoue (nagasone city, Japan)
| |
Criteria for PF-ILD in a cohort of patients with chronic hypersensitivity pneumonitis
E. Soares Seixas (Aveiro, Portugal), P. Serra (Aveiro, Portugal), M. Ferreira (Aveiro, Portugal), R. Aguiar (Aveiro, Portugal), P. Ferreira (Aveiro, Portugal)
| |
Prognostic characteristics in chronic hypersensitivity pneumonitis.
D. Neville (Portsmouth (Hampshire), United Kingdom), T. Jones (Portsmouth (Hampshire), United Kingdom), A. Tiwari (Birmingham, United Kingdom), V. Titmuss (Portsmouth, United Kingdom), A. Donaldson (Portsmouth, United Kingdom), K. Babu (Portsmouth, United Kingdom)
| |
Longitudinal functional evaluation of interstitial lung disease in systemic sclerosis
E. Palmer (Budapest, Hungary), V. Müller (Budapest, Hungary), A. Bohács (Budapest, Hungary), K. Vincze (Budapest, Hungary), N. Eszes (Budapest, Hungary)
| |
Progressive phenotype in primary Sjögren's syndrome-associated interstitial lung diseases: Prognostic significance
R. Sugawara (Osaka, Japan), T. Arai (Osaka, Japan), C. Sugimoto (Osaka, Japan), K. Tachibana (Osaka, Japan), M. Akira (Osaka, Japan), T. Kasai (Osaka, Japan), S. Hayashi (Osaka, Japan), Y. Inoue (Osaka, Japan)
| |
Six-Minute Walk Test in Interstitial Lung Disease : various outcomes for various causes
K. Ayed (Tunis, Tunisia), A. Chaker (Tunis, Tunisia), S. Mokaddem (Tunis, Tunisia), S. Khaldi (Tunis, Tunisia), S. Benkhamsa Jameleddine (Tunis, Tunisia)
| |
Short-term dynamic lung function and predictors of lung function decline in systemic sclerosis-related interstitial lung disease
P. Kaenmuang (Songkhla, Thailand), A. Navasakulpong (Songkhla, Thailand)
| |
Comparative analysis of collagen quantification in the bleomycin mouse model of lung fibrosis
M. Pittelli (Parma (PR), Italy), P. Caruso (Parma (PR), Italy), M. Faietti (Parma (PR), Italy), V. Pitozzi (Parma (PR), Italy), S. Pontis (Parma (PR), Italy), M. Bonatti (Parma (PR), Italy), B. Pioselli (Parma (PR), Italy), C. Frati (Parma (PR), Italy), D. Madeddu (Parma (PR), Italy), F. Quaini (Parma (PR), Italy), C. Lagrasta (Parma (PR), Italy), M. Civelli (Parma (PR), Italy), S. Catinella (Parma (PR), Italy), G. Villetti (Parma (PR), Italy), M. Trevisani (Parma (PR), Italy)
| |
Exhaled Volatile Organic Compounds are Able to Diagnose Systemic Sclerosis
J. Guiot (Liège, Belgium), D. Zanella (Liège, Belgium), P. Stefanuto (Liège, Belgium), L. Giltay (Liège, Belgium), M. Henket (Liège, Belgium), F. Guissard (Liège, Belgium), C. Moermans (Liège, Belgium), F. Schleich (Liège, Belgium), R. Louis (Liège, Belgium), J. Focant (Liège, Belgium)
| |
The Warrick score for the evaluation of chest CT scan manifestations of rheumatoid arthritis
H. Snène (Tunis, Tunisia), M. Attia (Tunis, Tunisia), H. Mrassi (Tunis, Tunisia), H. Blibech (Tunis, Tunisia), N. Mehiri (Tunis, Tunisia), A. Laater (Tunis, Tunisia), N. Ben Salah (Tunis, Tunisia), B. Louzir (Tunis, Tunisia)
| |
Idiopathic pulmonary fibrosis and systemic sclerosis-interstitial lung disease: features at admission to a tertiary pulmonology unit.
S. Vettori (Napoli, Italy), M. Lanza (Napoli, Italy), A. Annunziata (Napoli, Italy), R. Cauteruccio (Napoli, Italy), A. Coppola (Napoli, Italy), V. Di Spirito (Napoli, Italy), F. De Simone (Napoli, Italy), S. Gioia (Napoli, Italy), P. Imitazione (Napoli, Italy), F. Stefanelli (Napoli, Italy), G. Fiorentino (Napoli, Italy)
| |
Corticosteroids affect skeletal muscle strength in mild level of breathlessness of patients with interstitial lung disease
M. Hanada (nagasaki, Japan), Y. Ishimatsu (nagasaki, Japan), N. Sakamoto (nagasaki, Japan), H. Nagura (nagasaki, Japan), M. Oikawa (nagasaki, Japan), Y. Morimoto (nagasaki, Japan), H. Mukae (nagasaki, Japan), R. Kozu (nagasaki, Japan)
| |